Gossamer Bio GOSS
NASDAQ GOSS
$9.60 +0.14 (+1.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

Gossamer Bio (GOSS) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Gossamer Bio 38.40 Mn -435.00 Mn - 42.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.70 Mn
Mar 31, 2026 66.60 Mn
Dec 31, 2025 94.14 Mn
Sep 30, 2025 46.60 Mn
Jun 30, 2025 119.70 Mn
Mar 31, 2025 123.10 Mn
Dec 31, 2024 136.90 Mn
Sep 30, 2024 104.60 Mn
Jun 30, 2024 134.50 Mn
Mar 31, 2024 147.80 Mn
Dec 31, 2023 105.90 Mn
Sep 30, 2023 69.80 Mn
Jun 30, 2023 69.40 Mn
Mar 31, 2023 85.60 Mn
Dec 31, 2022 86.00 Mn
Sep 30, 2022 65.50 Mn
Jun 30, 2022 40.00 Mn
Mar 31, 2022 46.00 Mn
Dec 31, 2021 18.68 Mn
Sep 30, 2021 4.75 Mn
API Access

Gossamer Bio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GOSS&period=max&api_key=YOUR_API_KEY